Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2024

Feb 14, 2024

29745_dirs_2024-02-14_79945389-63b4-4a57-8cc5-d109cc5700a4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2024-02-12

Reporting Person: Jonsson Patrik (EVP&Pres, LLY Dia&Obe, LLY USA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-12 Common Stock A 5362 $737.26 Acquired 44583 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-12 Restricted Stock Unit $ A 3433 Acquired 2025-02-01 Common Stock (3433) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 537 Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.